Landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue: a systematic review and meta-analysis of transcriptomics studies.

Fecha de publicación:

Autores de CIPF

Participantes ajenos a CIPF

  • Moldovan RA
  • Castañé H
  • Jiménez-Franco A
  • Joven J

Grupos de Investigación

Abstract

Obesity represents a significant risk factor in the development of type 2 diabetes (T2D), a chronic metabolic disorder characterized by elevated blood glucose levels, and a previous step for its development. Significant sex differences have been identified in the prevalence, development, and pathophysiology of obesity and T2D; however, the underlying molecular mechanisms remain unclear. This study aims to identify sex-specific signatures in obesity and T2D and enhance our understanding of the underlying mechanisms associated with sex differences by integrating expression data. We performed a systematic review and individual transcriptomic analysis of eight selected studies which included 302 subcutaneous adipose tissue samples. Then, we conducted different gene-level meta-analyses and functional characterizations for obesity and T2D separately, identifying common and sex-specific transcriptional profiles, many of which were previously associated with obesity or T2D. The obesity meta-analysis yielded nineteen differentially-expressed genes from a sex-specific perspective (e.g., SPATA18, KREMEN1, NPY4R, and PRM3), while a comparison of the expression profiles between sexes in T2D prompted the identification and validation of specific transcriptomic signatures in males (SAMD9, NBPF3, LDHD, and EHD3) and females (RETN, HEY1, PLPP2, and PM20D2). At the functional level, we highlighted the fundamental role of the Wnt pathway in the development of obesity and T2D in females, and the roles of mitochondrial damage and free fatty acids in males. Overall, our sex-specific meta-analyses supported the detection of differentially expressed genes in males and females associated with the development of obesity and further T2D development, emphasizing the relevance of sex-based information in biomedical data and opening new avenues for research.

Datos de la publicación

ISSN/ISSNe:
0026-0495, 1532-8600

METABOLISM-CLINICAL AND EXPERIMENTAL  Elsevier BV

Tipo:
Article
Páginas:
156241-156241
PubMed:
40157598

Citas Recibidas en Web of Science: 3

Documentos

  • No hay documentos

Métricas

Filiaciones

Filiaciones no disponibles

Keywords

  • Meta-analysis, Molecular signature, Obesity, Sex differences, Subcutaneous adipose tissue, Transcriptomics, Type 2 diabetes

Proyectos asociados

PID10470. No se ingresará dinero en el CIPF. La ayuda consiste en un estudio genómico (long & read-sequencing) para 25 muestras.

Investigador Principal: CARMEN ESPINÓS ARMERO

EASI- Genomics . 2020

Substitución del ensayo embrionario murino por el ensayo embrionario ovino ( o como eviatr el sacrificio de un millón de ratones al año en Europa) - COLABORACION CON UM (DIRIGE UM)

Investigador Principal: DEBORAH J BURKS

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2022

Nanoplataforma Polipeptídica Multimodal de Precisión para el Tratamiento y Monitorización de Tumores Metastásicos. Colab I-36, I-12, I-63, servicio citómica, uji y gva (Esther Roselló)

Investigador Principal: MARIA JESUS VICENT DOCON

CONSELLERIA DE EDUCACION . 2022

ESTUDIO DE LAS DIFERENCIAS DE SEXO EN ENFERMEDADES NEURODEGENERATIVAS CON ABORDAJES

Investigador Principal: FRANCISCO GARCÍA GARCÍA

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2022

TECNICO INFRAESTRUCTURAS

Investigador Principal: FRANCISCO GARCÍA GARCÍA

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2024

CIACIF Antonio Porlan

Investigador Principal: FRANCISCO GARCÍA GARCÍA

GENERALITAT VALENCIANA

Metabolic strategies to stimulate myelin repair and prevent

MINISTERIO DE SANIDAD Y POL. SOC. E IGUAL.- PNSD . 2024

Impacto de la diferencia de sexo en las enfermedades de Park

Investigador Principal: FRANCISCO GARCÍA GARCÍA

GENERALITAT VALENCIANA . 2024

Expansión del Instituto Nacional de Bioinformática (INB) para incrementar su impacto internacional-Colaborador

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2025

EU4H-2024-JA-IBA-02 eCAN Plus

Investigador Principal: FRANCISCO GARCÍA GARCÍA

COMMISSION OF EUROPEAN COMMUNITIES . 2025

Compartir